Evaluating the Impact of PCSK9 on the Composition of the Tumor-Immune Microenvironment and Treatment Response to Immune Checkpoint Blockade in NSCLC

Administered By

Awarded By

Contributors

Start/End

  • July 1, 2021 - June 30, 2022